Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03593356 · ClinicalTrials.gov registry record · NA

Baby's First Years

A NA study of Child Development and Brain Development, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT03593356 is a NA study of Child Development and Brain Development that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 1,000 participants, roughly in line with the 1,062-participant average among 32 other Child Development trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03593356, a NA study of Child Development and Brain Development, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

Recent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's development is unknown. The project's team of neuroscientists, economists and developmental psychologists is seeking to fill important gaps in scientific knowledge about the role of economic resources in early development by evaluating the first U.S. randomized controlled trial to determine whether unconditional cash gift payments have a causal effect on the cognitive, socio-emotional and brain development of infants and toddlers in low-income U.S. families. Specifically, 1,000 mothers of infants with incomes below the federal poverty line from four diverse U.S. communities were recruited from post-partum wards and are receiving monthly cash gift payments by debit card for the first 76 months of the child's life. Parents in the experimental group and receiving $333 per month ($3,996 per year), whereas parents in the active comparator group are receiving a nominal monthly payment of $20. In order to understand the impacts of the added income on children's cognitive and behavioral development, the investigators are assessing treatment group differences at ages 4 (this lab assessment was postponed from age 3 to age 4 due to Covid-19), 6, and 8 in lab-administered measures of cognitive, language, and self-regulation development and maternal reports of socio-emotional development. A number of other maternal-reported child outcome measures were gathered at ages 1, 2 and 3. Brain circuitry may be sensitive to the effects of early experience even before early behavioral differences can be detected. In order to understand the impacts of added income on children's brain functioning at age 4, 6, and 8, the investigators will assess, during a lab visit, experimental/active comparator group differences in measu

Interventions

  • BEHAVIORAL Monthly cash gift payments of $333
  • BEHAVIORAL Monthly cash gift payments of $20

Study Locations (1)

New York

  • 12 hospitals in the following four metropolitan areas: New York, Omaha, New Orleans, and Twin Cities - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-05-09
Est. Completion 2028-08-31
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT03593356

The ClinicalTrials.gov registry entry for NCT03593356 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,062-participant average among 32 other Child Development trials with a reported enrollment target. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Child Development appearing as the primary indexed condition, and to 2 interventions - of which Monthly cash gift payments of $333 is the first listed.

NCT03593356 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03593356 about?

NCT03593356 is a clinical study titled "Baby's First Years". Recent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's development is unknown. The ...

What is the current status of trial NCT03593356?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2018-05-09. Estimated completion is 2028-08-31.

What conditions does trial NCT03593356 study?

This clinical trial studies the following conditions: Child Development, Brain Development, Household and Family Processes.

What interventions are being tested in trial NCT03593356?

The interventions under investigation include: Monthly cash gift payments of $333 (BEHAVIORAL), Monthly cash gift payments of $20 (BEHAVIORAL).

Who is sponsoring clinical trial NCT03593356?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03593356 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.